We are live on ! Find out more
PARN

Parnell Pharmaceuticals Holdings Ltd
PARN

Delisted

PARN was delisted on the 30th of December, 2016.

Back to rankings

14 hedge funds and large institutions have $14.9M invested in Parnell Pharmaceuticals Holdings Ltd in 2015 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

13% less funds holding

Funds holding: 16 → 14 (-2)

15% less capital invested

Capital invested by funds: $17.6M → $14.9M (-$2.61M)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ECM
Endurant Capital Management
California
+$529K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$232K
3
JP Morgan Chase
JP Morgan Chase
New York
+$144K
4
BIM
BlackRock Investment Management
Delaware
+$16.4K
5
UBS Group
UBS Group
Switzerland
+$13.1K

Top Sellers

1
AIC
AWM Investment Company
New York
-$1.34M
2
DM
Deerfield Management
New York
-$1.25M
3
PA
Perceptive Advisors
New York
-$563K
4
UOC
UBS O'Connor
Illinois
-$386K
5
BG
BlackRock Group
United Kingdom
-$124K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$4.04M – – –
BA
2
BlackRock Advisors
Delaware
$2.69M +$7.42K +1,681 +0.3%
AG
3
Artal Group
Luxembourg
$2.48M – – –
ECM
4
Endurant Capital Management
California
$2.02M +$529K +119,980 +42%
BG
5
BlackRock Group
United Kingdom
$1.11M -$124K -28,198 -11%
Alyeska Investment Group
6
Alyeska Investment Group
Illinois
$1.03M +$232K +52,558 +34%
JP Morgan Chase
7
JP Morgan Chase
New York
$580K +$144K +32,752 +39%
BIM
8
BlackRock Investment Management
Delaware
$442K +$16.4K +3,709 +4%
PA
9
Perceptive Advisors
New York
$341K -$563K -127,700 -65%
Goldman Sachs
10
Goldman Sachs
New York
$198K -$23.9K -5,408 -12%
UBS Group
11
UBS Group
Switzerland
$15K +$13.1K +2,967 New
TRCT
12
Tower Research Capital (TRC)
New York
$1K -$8.87K -2,010 -94%
LTFS
13
Ladenburg Thalmann Financial Services
Florida
$1K – – –
AIC
14
AWM Investment Company
New York
– -$1.34M -273,901 Closed
DM
15
Deerfield Management
New York
– -$1.25M -253,592 Closed
UOC
16
UBS O'Connor
Illinois
– -$386K -78,681 Closed
Morgan Stanley
17
Morgan Stanley
New York
– +$4 +1 +5%

PARN Hedge Fund Activity: Q2 2015 in Review

14 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Parnell Pharmaceuticals Holdings Ltd (PARN) for Q2 2015, worth a combined $14.9M — down 15% from $17.6M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PARN and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 6 added.

The largest buyer was Endurant Capital Management, adding an estimated $529K. The largest seller was AWM Investment Company, exiting entirely with an estimated $1.34M sold.

  • 14 institutional investors held Parnell Pharmaceuticals Holdings Ltd (PARN) as of Q2 2015, down from 16 in Q1 2015.
  • Funds reported $14.9M of Parnell Pharmaceuticals Holdings Ltd stock for Q2 2015, down 15% quarter-over-quarter.
  • 1 fund opened new Parnell Pharmaceuticals Holdings Ltd positions in Q2 2015 and 3 closed out, a net change of -2 holders.
  • The largest Parnell Pharmaceuticals Holdings Ltd buyer in Q2 2015 was Endurant Capital Management, an estimated $529K added.
  • The largest Parnell Pharmaceuticals Holdings Ltd seller in Q2 2015 was AWM Investment Company, an estimated $1.34M sold.

Based on aggregated 13F filings for Q2 2015.